SEC Form 4 · accession 0001246360-19-000739
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Peters
Director
Period of report
Feb 21, 2019
Accepted (ET)
Feb 25, 2019 · 1:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $22.78 | Feb 21, 2019 | D | 15,643 | D | Jun 25, 2017 | May 24, 2024 | Common Stock | 15,643 | 0 | D |
| Stock Option (Right to Buy) | $19.03 | Feb 21, 2019 | D | 17,537 | D | Jul 24, 2016 | Jun 23, 2023 | Common Stock | 17,537 | 0 | D |
Explanation of responses
- F1This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.